Lapidus Stanley 的 Form 4/A 修正申報
修正Lucid Diagnostics Inc.（LUCD），2023/9/27 申報
- 申報編號
- 0001062993-23-018551
- 申報時間
- 2023/9/27
- 交易日
- 2023/9/20-9/21
- 申報延遲
- 7 天
- 10b5-1 計畫
- 有勾選
- 原始申報日
- 2023/9/22
這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $5,674.53。交易後 7 天申報。
這份修正申報取代了 0001062993-23-018421（2023/9/22 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Lapidus StanleyCIK 0001678195 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/9/20 | Common stock | S賣出處分 | −3,405 | $1.45 | −$4,937.25 | 132,051 | 直接 | |
| 2023/9/20 | Common stock | S賣出處分 | −412 | $1.44 | −$593.28 | 131,639 | 直接 | |
| 2023/9/21 | Common stock | S賣出處分 | −100 | $1.44 | −$144 | 131,539 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.
- F2
Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023.
- F3
The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023.
備註
This Form 4 Amendment (this "Amendment") was filed with respect to the initial Form 4 filed September 22, 2023 (the "Initial Form 4") to clarify that the transactions reported on the Initial Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023. This is indicated on this Amendment by (i) the checking of the "Rule 10b5-1(c) Transaction Indication" box above Table I and (ii) the addition of Footnote 3. There are no other differences between this Amendment and the Initial Form 4.